DK0831797T3 - Farmaceutisk aktive carotenoider - Google Patents
Farmaceutisk aktive carotenoiderInfo
- Publication number
- DK0831797T3 DK0831797T3 DK96916256T DK96916256T DK0831797T3 DK 0831797 T3 DK0831797 T3 DK 0831797T3 DK 96916256 T DK96916256 T DK 96916256T DK 96916256 T DK96916256 T DK 96916256T DK 0831797 T3 DK0831797 T3 DK 0831797T3
- Authority
- DK
- Denmark
- Prior art keywords
- carotenoids
- pharmaceutically active
- zeaxanthin
- lutein
- active carotenoids
- Prior art date
Links
- 235000021466 carotenoid Nutrition 0.000 title abstract 5
- 150000001747 carotenoids Chemical class 0.000 title abstract 5
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract 4
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 abstract 2
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 abstract 2
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 abstract 2
- 206010064930 age-related macular degeneration Diseases 0.000 abstract 2
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 abstract 2
- 235000012680 lutein Nutrition 0.000 abstract 2
- 239000001656 lutein Substances 0.000 abstract 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract 2
- 229960005375 lutein Drugs 0.000 abstract 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract 2
- 208000002780 macular degeneration Diseases 0.000 abstract 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract 2
- 235000010930 zeaxanthin Nutrition 0.000 abstract 2
- 239000001775 zeaxanthin Substances 0.000 abstract 2
- 229940043269 zeaxanthin Drugs 0.000 abstract 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 abstract 1
- 206010025421 Macule Diseases 0.000 abstract 1
- 240000003768 Solanum lycopersicum Species 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48762795A | 1995-06-07 | 1995-06-07 | |
| GBGB9604221.3A GB9604221D0 (en) | 1995-06-07 | 1996-02-28 | Pharmaceutically active carotenoids |
| PCT/GB1996/001368 WO1996040092A1 (en) | 1995-06-07 | 1996-06-07 | Pharmaceutically active carotenoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0831797T3 true DK0831797T3 (da) | 2007-04-02 |
Family
ID=26308821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96916256T DK0831797T3 (da) | 1995-06-07 | 1996-06-07 | Farmaceutisk aktive carotenoider |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0831797B1 (da) |
| AT (1) | ATE355832T1 (da) |
| AU (1) | AU719671B2 (da) |
| CA (1) | CA2224217C (da) |
| DE (1) | DE69636951T2 (da) |
| DK (1) | DK0831797T3 (da) |
| ES (1) | ES2283002T3 (da) |
| GB (1) | GB2301775B (da) |
| NZ (1) | NZ309130A (da) |
| WO (1) | WO1996040092A1 (da) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5827652A (en) | 1995-10-31 | 1998-10-27 | Applied Food Biotechnology, Inc. | Zeaxanthin formulations for human ingestion |
| CA2188983C (en) * | 1995-10-31 | 2001-02-27 | Kevin M. Garnett | Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans |
| US5747544A (en) * | 1995-10-31 | 1998-05-05 | Applied Food Biotechnology, Inc. | Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans |
| WO1997048388A1 (en) * | 1996-06-17 | 1997-12-24 | The Board Of Trustees Of The University Of Illinois | Method of retarding and ameliorating central nervous system and eye damage |
| GB9704972D0 (en) * | 1997-03-11 | 1997-04-30 | Howard Foundation | Flicker photometer |
| AU5416998A (en) * | 1997-10-14 | 1999-05-03 | Quest International B.V. | Preparation for the enhancement of the antioxidant status of cells |
| AU745973B2 (en) * | 1998-03-18 | 2002-04-11 | Kemin Industries, Inc. | Increased bioavailability of lutein and zeaxanthin in humans and poultry using lysolecithin and lecithin |
| US6191293B1 (en) | 1998-04-20 | 2001-02-20 | Inexa, Industria Extractora C.A. | Trans-xanthophyll ester concentrates of enhanced purity and methods of making same |
| NL1010351C2 (nl) * | 1998-10-19 | 2001-01-08 | Werklust & Beheer B V | Esters van caroteno´den voor gebruik in de preventie en behandeling van oogaandoeningen. |
| IT1307281B1 (it) | 1999-11-25 | 2001-10-30 | Simonelli Giuseppe | Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva, |
| US7691406B2 (en) | 2000-10-27 | 2010-04-06 | ZeaVision LLC. | Zeaxanthin formulations for human ingestion |
| DE10112067A1 (de) | 2001-03-12 | 2002-09-19 | Basf Ag | Verfahren zur Herstellung von 2,7-Dimethyl-2,4,6-octarienal-monoacetalen |
| US6660297B2 (en) | 2001-03-23 | 2003-12-09 | Bausch & Lomb Incorporated | Nutritional supplement to treat macular degeneration |
| JP2004532831A (ja) * | 2001-03-27 | 2004-10-28 | シー．エス． バイオサイエンス、 インコーポレイテッド | 歯科用調剤 |
| US6784351B2 (en) | 2001-06-29 | 2004-08-31 | Ball Horticultural Company | Targetes erecta marigolds with altered carotenoid compositions and ratios |
| US7575766B2 (en) | 2001-06-29 | 2009-08-18 | Ball Horticultural Company | Tagetes erecta with altered carotenoid compositions and ratios |
| US7081478B2 (en) * | 2001-06-29 | 2006-07-25 | Chrysantis, Inc. | Mixed zeaxanthin ester concentrate and uses thereof |
| DE10141018A1 (de) * | 2001-08-22 | 2003-03-13 | Eth Zuerich Eidgenoessische Te | Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges |
| WO2003063848A1 (en) * | 2002-01-30 | 2003-08-07 | Dsm Ip Assets B.V. | Lutein/zeaxanthin for glare protection |
| EP1476143A1 (en) * | 2002-02-15 | 2004-11-17 | DSM IP Assets B.V. | Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| US7223909B2 (en) | 2002-03-21 | 2007-05-29 | Ball Horticultural | 4-ketocarotenoids in flower petals |
| US20030228392A1 (en) * | 2002-06-06 | 2003-12-11 | Wyeth | Infant formula compositions containing lutein and zeaxanthin |
| EP1864654A1 (en) * | 2002-06-06 | 2007-12-12 | Wyeth a Corporation of the State of Delaware | Infant formula compositions containing lutein and zeaxanthin |
| US7320997B2 (en) | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
| US7145025B2 (en) | 2002-07-29 | 2006-12-05 | Hawaii Biotech, Inc. | Structural carotenoid analogs for the inhibition and amelioration of disease |
| US7375133B2 (en) | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| US7521584B2 (en) | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
| US7345091B2 (en) | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
| US8088363B2 (en) | 2002-10-28 | 2012-01-03 | Zeavision Llc | Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
| US9192586B2 (en) | 2003-03-10 | 2015-11-24 | Zeavision Llc | Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders |
| DE20300304U1 (de) * | 2003-01-09 | 2003-04-24 | Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin | Ocuvite Zink |
| DE20300305U1 (de) | 2003-01-09 | 2003-04-24 | Mann Gerhard Chem Pharm Fab | Ocuvite Lutein |
| US7941211B2 (en) | 2003-11-17 | 2011-05-10 | Zeavision, Llc. | Preloading with macular pigment to improve photodynamic treatment of retinal vascular disorders |
| DE20320101U1 (de) | 2003-12-23 | 2004-04-29 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Mikronährstoffkombinationsprodukt geeignet zur ergänzenden bilanzierten Diät bei altersbedingter Makuladegeneration |
| US7351424B2 (en) | 2004-07-22 | 2008-04-01 | Bio Lut S.A. De C.V. | Enhanced purity trans-lutein-ester compositions and methods of making same |
| WO2006055526A2 (en) * | 2004-11-16 | 2006-05-26 | Nu-Tein Co., Inc. | Compositions useful to treat ocular neovascular diseases and macular degeneration |
| EP1861078A2 (en) * | 2005-02-11 | 2007-12-05 | Kalamazoo Holdings, Inc. | A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
| US8592662B2 (en) | 2005-02-11 | 2013-11-26 | Kalamazoo Holdings, Inc. | Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom |
| CA2611137A1 (en) * | 2005-03-23 | 2006-09-28 | Cardax Pharmaceuticals, Inc. | Water-dispersible carotenoids, including analogs and derivatives |
| WO2007029008A2 (en) * | 2005-09-08 | 2007-03-15 | Dsm Ip Assets B.V. | Method of treatment or prevention of age-related macular degeneration |
| EP1920711A1 (en) * | 2006-11-13 | 2008-05-14 | DSMIP Assets B.V. | Assessment and improvement of visual performance |
| US8063101B2 (en) | 2007-03-23 | 2011-11-22 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs and derivatives for the prevention of platelet aggregation |
| DK2473065T3 (da) | 2009-09-02 | 2016-06-27 | Omniactive Health Tech Ltd | Xanthophyl-sammensætning indeholdende makuløse pigmenter og en fremgangsmåde til fremstilling deraf |
| WO2011076869A1 (en) * | 2009-12-22 | 2011-06-30 | Aakerlund Hans-Erik | Isolated green plant material |
| CA2837047C (en) * | 2011-07-07 | 2019-04-23 | Howard Foundation Holdings Ltd | Improvements in or relating to visual performance and/or macular pigmentation |
| CA2841411C (en) | 2011-07-13 | 2017-09-12 | University Of Georgia Research Foundation, Inc. | Use of xanthophyll carotenoids to improve visual performance and neural efficiency |
| DE102017009186A1 (de) | 2017-09-25 | 2019-03-28 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Lutein und -derivate enthaltende Zusammensetzung sowie Verfahren zur Herstellung |
| EP4254344B1 (en) | 2022-03-31 | 2025-07-09 | Imagination Technologies Limited | Parallel optimisation of bounding volume hierarchy |
| CN114831310B (zh) * | 2022-04-13 | 2023-04-21 | 华南农业大学 | 一种改善视力的组合物 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2236899A1 (de) * | 1972-07-27 | 1974-02-07 | Philips Patentverwaltung | Mit wasser mischbare carotinoidemulsion |
| CH598197A5 (da) * | 1974-10-07 | 1978-04-28 | Hoechst Ag | |
| JPS5320036A (en) * | 1976-08-04 | 1978-02-23 | Kubota Ltd | Cooler of radiator etc. |
| US4048203A (en) * | 1976-12-06 | 1977-09-13 | Thomas Philip | Purification of lutein-fatty acid esters from plant materials |
| DE2923032A1 (de) * | 1979-06-07 | 1980-12-11 | Waldemar Hankin | Arzneimittel auf der basis von reiher- eidotter |
| JPS6065033A (ja) * | 1983-09-20 | 1985-04-13 | Toshiba Corp | 軽量強化材料の製造方法 |
| JPS6157298A (ja) * | 1984-08-30 | 1986-03-24 | Nippon Kokan Kk <Nkk> | 閉鎖水域の浄化装置 |
| AU623978B2 (en) * | 1989-02-28 | 1992-05-28 | Nisshin Flour Milling Co. Ltd. | Stabilized fat-soluble vitamin compositions |
| IL90794A (en) * | 1989-06-29 | 1995-03-15 | Shapira Niva | Nutritional sun-exposure supporting composition |
| US5290605A (en) * | 1989-06-29 | 1994-03-01 | Niva Shapira | Sun-exposure nutritional supporting composition |
| ATE153700T1 (de) * | 1989-08-30 | 1997-06-15 | Applied Food Biotech Inc | Verfahren zur herstellung einer zeaxanthin enthaltenden zusammensetzung mittels eines mikroorganismus der spezies flavobacterium multivorum |
| GB9105420D0 (en) * | 1991-03-14 | 1991-05-01 | Ici Plc | Expression of genes in transgenic plants |
| JPH05163143A (ja) * | 1991-12-16 | 1993-06-29 | Nisshin Flour Milling Co Ltd | α−トコフェロールビタミンＡ酸エステル含有油性組成物 |
| US5310764A (en) * | 1992-05-08 | 1994-05-10 | Steven Baranowitz | Treatment of age related macular degeneration with beta-carotene |
| JPH05320036A (ja) * | 1992-05-19 | 1993-12-03 | Shiseido Co Ltd | 一重項酸素除去組成物 |
| JPH0665033A (ja) * | 1992-08-11 | 1994-03-08 | Lion Corp | 口腔用組成物 |
| JPH06157298A (ja) * | 1992-11-26 | 1994-06-03 | Otsuka Pharmaceut Co Ltd | 注射用脂肪乳剤 |
| GB2274235B (en) * | 1993-01-13 | 1996-06-26 | Neo Life Company Of America | Carotenoid food supplement |
| IL110139A0 (en) * | 1993-06-28 | 1994-10-07 | Howard Foundation | Pharmaceutically-active antioxidants |
| US5382714A (en) * | 1994-03-17 | 1995-01-17 | The Catholic University Of America | Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof |
| WO1996019215A1 (en) * | 1994-12-22 | 1996-06-27 | Henkel Corporation | Compositions of tocopherol and beta-carotene |
| ATE201380T1 (de) * | 1995-03-10 | 2001-06-15 | Inventio Ag | Einrichtung und verfahren zur schwingungsdämpfung an einer aufzugskabine |
-
1996
- 1996-06-07 DK DK96916256T patent/DK0831797T3/da active
- 1996-06-07 GB GB9611967A patent/GB2301775B/en not_active Expired - Lifetime
- 1996-06-07 AU AU59078/96A patent/AU719671B2/en not_active Expired
- 1996-06-07 NZ NZ309130A patent/NZ309130A/en not_active IP Right Cessation
- 1996-06-07 DE DE69636951T patent/DE69636951T2/de not_active Expired - Lifetime
- 1996-06-07 EP EP96916256A patent/EP0831797B1/en not_active Expired - Lifetime
- 1996-06-07 CA CA2224217A patent/CA2224217C/en not_active Expired - Lifetime
- 1996-06-07 AT AT96916256T patent/ATE355832T1/de active
- 1996-06-07 ES ES96916256T patent/ES2283002T3/es not_active Expired - Lifetime
- 1996-06-07 WO PCT/GB1996/001368 patent/WO1996040092A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996040092A1 (en) | 1996-12-19 |
| AU719671B2 (en) | 2000-05-18 |
| GB2301775B (en) | 1999-08-04 |
| ATE355832T1 (de) | 2007-03-15 |
| DE69636951T2 (de) | 2007-11-22 |
| EP0831797B1 (en) | 2007-03-07 |
| CA2224217A1 (en) | 1996-12-19 |
| GB2301775A (en) | 1996-12-18 |
| AU5907896A (en) | 1996-12-30 |
| DE69636951D1 (de) | 2007-04-19 |
| NZ309130A (en) | 2001-06-29 |
| EP0831797A1 (en) | 1998-04-01 |
| ES2283002T3 (es) | 2007-10-16 |
| CA2224217C (en) | 2010-04-13 |
| GB9611967D0 (en) | 1996-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355832T1 (de) | Pharmazeutisch aktive karotenoide | |
| ES2061799T3 (es) | Nuevo preparado medicamentoso y procedimiento para su preparacion. | |
| ES2126536A1 (es) | "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion. | |
| HUP9902012A2 (hu) | Porfirinszármazékok alkalmazása látásjavító gyógyszerkészítmények előállítására | |
| DK1011653T3 (da) | Anvendelse af xanthophyller i medikamenter til forbedring af varigheden af muskelfunktion eller behandling af muskelforstyrrelser eller -lidelser | |
| AR036448A1 (es) | Composiciones farmaceuticas de conjugados droga insulina-oligomeros, y metodos para tratar las enfermedades con los mismos | |
| ES2062392T3 (es) | Medicamentos que comprenden salmeterol y fluticasona. | |
| UY26372A1 (es) | "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen " | |
| ES2093440T3 (es) | Derivados en la serie de la vitamina d con modificaciones en la posicion 20, procedimiento para su preparacion, productos intermedios para este procedimiento, preparados farmaceuticos que contienen estos derivados asi como su utilizacion para la preparacion de medicamentos. | |
| EP1470817A4 (en) | COMPOSITIONS FOR PREVENTING CANCER IN HUMANS AND METHOD FOR PREVENTING CANCER IN HUMANS | |
| BR9811086A (pt) | Utilização de preparados de eritropoietina e ferro, processo para a produção de um preparado de combinação farmacêutica e embalagem unitária farmacêutica | |
| AR017877A1 (es) | Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo | |
| RU2341252C2 (ru) | Каротиноидная композиция и способ защиты кожи | |
| RU2003122060A (ru) | Каротиноиды в качестве антигипертензивных агентов | |
| KR20050043784A (ko) | 세포의 활성을 감소시키기 위한 방법 및 약학적 제조물 | |
| UY25510A1 (es) | Procedimiento para la producción de preparados efervescentes | |
| BR9908891A (pt) | Processos para aumentar a absorção e biodisponibilidade de carotenóides em humanos e aves domésticas, para aumentar a deposição dos carotenóides nos tecidos e gemas de ovo de aves domésticas, e para aumentar a deposição dos carotenóides nos tecidos, incluindo o sangue e a região macular da retina, de humanos, e, suplemento de alimento para aumentar a absorção e biodisponibilidade dos carotenóides em humanos e aves domésticas | |
| SE9803541D0 (sv) | Treatment of dyspepsia | |
| WO2002041897A3 (fr) | Compositions pharmaceutiques a action antidiabetique constitues de l'association d'un biguanide et d'un sulfonamide | |
| US10299503B2 (en) | N-acetyl cysteine based compositions | |
| Dharmananda | Lycium Fruit | |
| AR024590A1 (es) | Metodo para la preparacion de aglutinados proteicos, aglutinados proteicos, y un producto alimenticio y un preparado farmaceutico que contengan estas. | |
| ES2138668T3 (es) | Nuevos derivados de peptidos terapeuticamente activos en la cadena de coagulacion sanguinea, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| IT8448710A1 (it) | Riduzione degli effetti tossici causati da farmaci antrachinonici | |
| RU2005128412A (ru) | Способ профилактики и лечения задержаний последов и эндометритов у животных, например у коров, пенообразующими препаратами |